The present invention relates generally to a novel haemopoietin receptor or components
or part thereof and to genetic sequences encoding same. The receptor molecules
and their components and/or parts and the genetic sequences encoding same of the
present invention are useful in the development of a wide range of agonists, antagonists,
therapeutics and diagnostic reagents based on ligand interaction with its receptor.
